Strides Pharma Science Ltd.

BSE: 532531 | NSE: STAR |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE939A01011 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Strides Pharma Strides Pharma Science Ltd. | BSE 875.30 -8.90 (-1.01%) | NSE 875.60 -6.90 (-0.78%) | Trade | Add

BSE Live

Feb 11, 16:01

875.30 -8.90 (-1.01%)

Volume

AVERAGE VOLUME

5-Day

9,383

10-Day

47,688

30-Day

27,579

4,651

Prev. Close

884.20
Open Price

899.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Feb 11, 15:55

875.60 -6.90 (-0.78%)

Volume

AVERAGE VOLUME

5-Day

277,081

10-Day

905,534

30-Day

535,381

228,800

Prev. Close

882.50
Open Price

884.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
875.60 (94)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Strides Pharma Science (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	1,533.78	1,386.02	1,307.38	1,269.35	2,137.77
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	57.79
Revenue From Operations [Net]	1,533.78	1,386.02	1,307.38	1,269.35	2,079.98
Total Operating Revenues	1,674.15	1,537.44	1,469.61	1,381.82	2,203.49
Other Income	100.16	114.61	156.20	169.06	140.96
Total Revenue	1,774.31	1,652.04	1,625.81	1,550.87	2,344.45
EXPENSES
Cost Of Materials Consumed	848.34	903.77	759.15	634.79	1,159.43
Purchase Of Stock-In Trade	38.46	20.58	39.89	112.38	90.82
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	1.18	-45.52	-17.79	-12.71	4.48
Employee Benefit Expenses	221.77	223.21	224.54	228.48	274.97
Finance Costs	66.71	54.09	81.97	71.96	102.71
Depreciation And Amortisation Expenses	91.63	83.00	77.81	70.01	105.85
Other Expenses	354.37	296.35	266.73	248.16	391.74
Total Expenses	1,622.46	1,535.49	1,432.29	1,353.07	2,129.99
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	151.86	116.56	193.51	197.81	214.46
Exceptional Items	0.00	-3.52	-29.38	-15.16	-25.18
Profit/Loss Before Tax	151.86	113.03	164.13	182.65	189.29
Tax Expenses-Continued Operations
Current Tax	19.79	24.63	37.32	11.84	32.71
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	32.71
Deferred Tax	20.37	-26.01	-29.64	18.87	33.51
Tax For Earlier Years	0.00	0.00	0.00	0.00	-5.29
Total Tax Expenses	40.16	-1.38	7.69	30.71	28.21
Profit/Loss After Tax And Before ExtraOrdinary Items	111.70	114.41	156.45	151.94	161.07
Profit/Loss From Continuing Operations	111.70	114.41	156.45	151.94	161.07
Profit/Loss For The Period	111.70	110.37	891.59	108.54	161.07
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	12.47	12.33	99.64	12.14	19.50
Diluted EPS (Rs.)	12.47	12.32	99.61	12.12	19.38
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	466.27
Indigenous Raw Materials	0.00	0.00	0.00	0.00	693.16
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	0.00
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	0.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	156.30	17.91	47.82	43.23	42.46
Tax On Dividend	0.00	0.00	0.00	0.00	8.89
Equity Dividend Rate (%)	140.00	30.00	20.00	45.00	40.00